SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-019423
Filing Date
2023-01-31
Accepted
2023-01-30 20:48:15
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d443818ds3.htm S-3 216397
2 EX-4.2 d443818dex42.htm EX-4.2 316515
3 EX-5.1 d443818dex51.htm EX-5.1 30658
4 EX-23.1 d443818dex231.htm EX-23.1 1583
5 EX-FILING FEES d443818dexfilingfees.htm EX-FILING FEES 52534
6 GRAPHIC g443818g03q72.jpg GRAPHIC 33280
7 GRAPHIC g443818g76a10.jpg GRAPHIC 8128
8 GRAPHIC g443818g76a11.jpg GRAPHIC 15069
  Complete submission text file 0001193125-23-019423.txt   691319
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-269471 | Film No.: 23569925
SIC: 2834 Pharmaceutical Preparations